Olympus Recalls ShockPulse-SE Lithotripsy Systems Due to Mis-wired Components
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Olympus Corporation of the Americas has recalled 55 ShockPulse-SE Lithotripsy Systems distributed internationally due to a mis-wired component that may cause treatment delays.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 3, 2026 and geographically references Canada, Germany, Singapore, Australia, India. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Olympus Corporation of the Americas has initiated a voluntary recall of the ShockPulse-SE Lithotripsy System with Generator. The recall was prompted by the discovery of a mis-wired component within the system's generator. This defect can result in additional electrical noise on the power supply output, which is inconsistent with electromagnetic compatibility (EMC) standards. This noise may decrease the overall reliability of the system and potentially lead to delays in medical treatment.
Which Products Are Affected
The recall affects 55 units distributed internationally. The affected products include:
- Brand Name: Olympus ShockPulse-SE Lithotripsy System with Generator
- Product Name: ShockPulse-SE Lithotripsy System - Reuseable Probes
- Model/Catalog Number: SPL-SR (contains generator SPL-G)
- UDI: SPL-SR 00821925043824, SPL-G 00821925044203
- Serial Numbers: CG5026, CG5027, CG5028, CG5029, CG5030, CG5031, CG5032, CG5033, CG5034, CG5035, CG5036, CG5037, CG5039, CG5040, CG5041, CG5042, CG5043, CG5045, CG5046, CG5047, CG5048, CG5049, CG5050, CG5051, CG5052, CG5053, CG5054, CG5055, CG5056, CG5057, CG5058, CG5059, CG5060, CG5061, CG5062, CG5063, CG5065, CG5066, CG5067, CG6037, CG6061, CG6069, CG6070, CG6071, CG6088, CG6094, CG6095, CG6096, CG6097, CG6098, CG6099, CG7000, CG7001, CG7002, CG7003.
These units were distributed in Canada, Germany, Singapore, Australia, and India.
What You Should Do
The recalling firm, Olympus Corporation of the Americas, initiated notification to affected parties via letter on January 8, 2026. Healthcare facilities and distributors in the affected regions should identify if they possess any of the listed serial numbers and follow the specific instructions provided in the firm's notification letter regarding the impacted devices.
Why This Matters
The mis-wired component compromises the system's adherence to safety and electromagnetic standards. This failure can lead to equipment instability and unexpected delays during surgical procedures intended to fragment urinary tract stones, potentially impacting patient care.
Source
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category